Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-24-000258
Filing Date
2024-08-02
Accepted
2024-08-02 16:15:29
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q esgh-20240630_10q.htm   iXBRL 10-Q 548341
2 EX-31.1 esgh-20240630_ex31z1.htm EX-31.1 11260
3 EX-32.1 esgh-20240630_ex32z1.htm EX-32.1 4631
9 GRAPHIC image_01.jpg GRAPHIC 62556
  Complete submission text file 0001520138-24-000258.txt   3965175

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE esgh-20240630.xsd EX-101.SCH 38253
5 XBRL CALCULATION FILE esgh-20240630_cal.xml EX-101.CAL 60453
6 XBRL DEFINITION FILE esgh-20240630_def.xml EX-101.DEF 92918
7 XBRL LABEL FILE esgh-20240630_lab.xml EX-101.LAB 249770
8 XBRL PRESENTATION FILE esgh-20240630_pre.xml EX-101.PRE 206511
76 EXTRACTED XBRL INSTANCE DOCUMENT esgh-20240630_10q_htm.xml XML 511209
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

EIN.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56532 | Film No.: 241171189
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)